A Study to Evaluate the Safety and Tolerability of MEDI0382 in Overweight and Obese Participants with Type 2 Diabetes Mellitus

Trial Identifier: D5670C00030
Sponsor: MedImmune, LLC
NCTID:: NCT03745937
Start Date: January 2019
Primary Completion Date: May 2019
Condition: Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
German Translation

Trial Locations

Country Location
Germany Neuss, Germany, 41460